Transaction · 0001104659-26-106338

Hooftman Leon

Hooftman Leon, CMO, reported a transaction classified as grant at Barinthus Biotherapeutics plc. involving 361530.000000 shares. Reported holdings after the transaction were 361530.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

grantSEC transaction code ACMO
BRNSBarinthus Biotherapeutics plc.
Trade date
Sep 09, 2026
Filing date
Sep 09, 2026
View on SEC Insider profile
Estimated value—Shares × reported price
Shares traded361kPrice unknown
Holdings after361kDirect
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Filing warnings

Notes recorded with this filing
1 warning
missing priceThe filing did not provide a usable price per share.

BRNS price since this filing

Daily closing prices, with the filing date and available return windows
BRNS · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Non-derivative
Type
grant
Code A
Identifier
0001104659-26-106338
Ordinary Shares
Transaction date
Sep 09, 2026
Filed Sep 09, 2026, 08:19 PM · 0d delay
Shares
361,530 sh
Price unknown
Estimated value
—
Computed from shares × price
Holdings after
361,530 sh
Direct

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Direct Ownership Large Holdings Increase
Filing-only score

-20 points

Compact filing score computed from stored Form 4 facts. Version v1.

Low filing signal

This filing has a meaningfully negative filing-only score. It is likely less useful as a positive insider-activity signal.

How this score is calculated
  • direct_ownership+6 points

    direct_or_indirect_ownership = D

    Direct ownership reports the insider's personal stake.
  • timely_filing+4 points

    reporting_delay_days = 0

    Filing reported within two business days of the transaction.
  • grant_or_award-22 points

    transaction_code = A

    Grant or award transactions are scheduled compensation, not discretionary.
  • missing_price-8 points

    price_cents is null

    Missing price reduces confidence in value-based signals.
Missing facts
  • price_cents
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

Chief Medical Officer

Officer YesDirector No10% NoOther No
Footnotes & amended
  1. F1

    The Ordinary Shares may be represented by American Depositary Shares ("ADSs" and together with the Ordinary Shares, the "Shares"), each of which currently represents one Ordinary Share.

  2. F2

    This Form 4 reports securities transacted in connection with the Agreement and Plan of Merger, dated September 29, 2025, as amended (the "Merger Agreement") by and among the Issuer, Beacon Topco, Inc.…

  3. F3

    Represents restricted share units ("RSUs") previously granted to the Reporting Person, vesting of which was subject to completion of the transactions contemplated by the Merger Agreement. Each RSU rep…

  4. F4

    Pursuant to the Merger Agreement, at the Effective Time, each option to acquire Shares under the Issuer's equity plans that was outstanding as of immediately prior to the Effective Time ceased to repr…

Original filing · 0001104659-26-106338
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

BRNS